Stay updated on Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.

Latest updates to the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a minor platform update rather than any changes to study details or content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.3, indicating a newer version of the page. This editorial update does not change the study details or outcomes.SummaryDifference0.1%

- Check48 days agoChange DetectedRecruitment status updated: Arms B and C are closed to enrollment, while Arm A remains open for enrollment.SummaryDifference0.4%

- Check55 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing Revision: v3.5.4. This reflects a site release update and does not modify trial information.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3. This update appears to be a version label change rather than a substantive modification to the study content or results.SummaryDifference0.1%

- Check98 days agoChange DetectedThe page’s footer is updated to reflect a new software/website revision (from v3.5.2 to v3.5.3). This represents a versioning change rather than a change to the trial information.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.